Increasing Equity in Lung Cancer Screening
LUCARE
1 other identifier
interventional
144
1 country
1
Brief Summary
The overall objective of this mixed methods study is to: 1) Refine the Emergency Department Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy, acceptability, and feasibility; and 3) provide an in-depth description of stakeholders' experiences with the ED-LCS intervention for future refinement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lung-cancer
Started Dec 2023
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 25, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
August 6, 2025
August 1, 2025
3.2 years
March 25, 2024
August 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of patients receive Lung Cancer Screening
6-12 months
Secondary Outcomes (1)
Patients ratings of intervention
At delivery
Study Arms (2)
Intervention
EXPERIMENTALPatients will be shown a modified version of LungTalk.
Usual Care
NO INTERVENTIONPatients will receive usual care.
Interventions
This is a lung cancer educational intervention for patients in the emergency department.
Eligibility Criteria
You may qualify if:
- Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years)
You may not qualify if:
- Non-English/Spanish speaking
- Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment
- Intoxicated with alcohol or drugs
- Cannot provide reliable follow up contact information (cell phone)
- Presenting to the ED with a life-threatening condition
- Have received chest CT scan in past 12 months
- Already enrolled in LCS
- Hospice enrolled
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Eskenazi Healthcollaborator
Study Sites (1)
Eskenazi Health
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 25, 2024
First Posted
April 11, 2024
Study Start
December 1, 2023
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
August 6, 2025
Record last verified: 2025-08